Skip to main content

SYSTEMATIC REVIEW article

Front. Oncol.
Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1487198
This article is part of the Research Topic Harnessing Nanotechnology for Cancer Treatment View all articles

Seeing Beyond Words: Nanotechnology in Hepatocellular Carcinoma -A Bibliometric Study

Provisionally accepted
Talaiti Tuergan Talaiti Tuergan Aimitaji Abulaiti Aimitaji Abulaiti Alimu Tulahong Alimu Tulahong Ruiqing Zhang Ruiqing Zhang Zhongdian Yuan Zhongdian Yuan Yanze Lin Yanze Lin Yingmei Shao Yingmei Shao Tuerganaili Aji Tuerganaili Aji *
  • First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

The final, formatted version of the article will be published soon.

    Background: Nanotechnology has increasingly been applied in the diagnosis and treatment of hepatocellular carcinoma (HCC) over the past two decades. This study aims to explore the utilization of nanotechnology in HCC through a bibliometric analysis, identifying key themes, trends, and contributions in this field.The study utilized VOSviewer and CiteSpace software to perform a bibliometric analysis, evaluating scholarly contributions related to nanotechnology in HCC. The analysis focused on co-occurrence network relationships, publications, citations, and contributions from various entities and authors.The analysis revealed a total of 2,968 articles, with China and the USA being the most prominent contributors in terms of publications and citations. Notable contributions were made by the Chinese Academy of Sciences and authors Gao Jie and Li Yan. LLOVET JM emerged as the most co-cited author, indicating a leadership role in the field. The "International Journal of Nanomedicine" was identified as the leading publisher, while "Biomaterials" ranked highest in citations. The research mainly focused on drug delivery systems and apoptosis, highlighting significant advancements in utilizing nanotechnology for HCC treatment.This bibliometric study underscores the critical role of nanotechnology in advancing the diagnosis and treatment of hepatocellular carcinoma, with a particular emphasis on drug delivery and apoptosis. The findings highlight the contributions of key countries, institutions, and authors, reflecting the global effort and collaboration in this rapidly evolving field.

    Keywords: Nanotechnology, Hepatocellular Carcinoma, Bibliometrics, Drug delivery, Apoptosis

    Received: 27 Aug 2024; Accepted: 17 Dec 2024.

    Copyright: © 2024 Tuergan, Abulaiti, Tulahong, Zhang, Yuan, Lin, Shao and Aji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Tuerganaili Aji, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.